Date |
Event |
Presentation |
Speakers |
February 10, 2014
|
Predictive Preclinical Models in Oncology
|
Microenvironmental Regulation of GBM Progression and Therapeutic Resistance
|
Gabrielle Bergers
|
|
|
Pfizer’s Strategy for the Application of Preclinical Models to Fuel Discovery Biology and Drug Discovery
|
Peter Olson
|
May 31, 2013
|
ASCO Annual Meeting 2013
|
Education Sessions
|
Alan Venook
|
April 6, 2013
|
AACR Annual Meetings
|
BRAF Pathway Inhibitors in Melanoma: Where Do We Go from Here? Chairperson: Richard M. Marais, Paterson Institute for Cancer Research, Manchester, United Kingdom
|
Martin McMahon
|
|
|
Translational Control and Stress Response Pathways in Cancer Chairperson: Davide Ruggero, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
|
Davide Ruggero
|
|
|
Next-Generation Therapeutic Modeling in Mice
|
Allan Balmain
|
|
|
The Next Frontier in Targeted Therapy for Melanoma Chairperson to be announced
|
Martin McMahon
|
October 4, 2012
|
14th Annual Lynn Sage Breast Cancer Symposium
|
Current Status of Antiangiogenics
|
Hope S. Rugo
|
January 19, 2012
|
9th Annual Natural Supplements: An Evidence-Based Update
|
B. Integrative Oncology
|
Donald Abrams
|
|
|
Integrative Cancer Care
|
Donald Abrams
|
January 12, 2011
|
Antibodies for the 21st Century
|
Energy-Based Analysis and Prediction of the Orientation between Light- and Heavy-Chain Antibody Variable Domains
|
Matt Jacobson
|
October 20, 2010
|
6th Annual Meeting of the Oligonucleotide Therapeutics Society
|
Global measurements of translation by ribosome profiling
|
Nick Ingolia
|
|
|
The application of activating dsRNA (RNAa) on gene expression in iPS cells
|
Long-Cheng Li
|
September 30, 2010
|
Third AACR Conference on The Science of Cancer Health Disparities
|
Disparities in treatment decision making watchful waiting/expectant management of indolent prostate cancer
|
Mack Roach
|
|
|
The imperative of mixed methods for cancer disparities research
|
Rena J. Pasick
|
|
|
Contexts of clinical trials decision making: A multimethod approach
|
Nancy J. Burke
|
|
|
Plenary Session 1: Blending Methodologies to Optimize Cancer Disparities Research
|
Rena J. Pasick
|
September 30, 2010
|
Third AACR Conference on the Science of Cancer Health Disparities in Racial / Ethnic Minorities and the Medically Underserved
|
Strategic considerations in applying US-conceived models in cultures or settings other than those in which they were tested
|
Lawrence W. Green
|
|
|
Contexts of clinical trials decision making: A multimethod approach
|
Nancy J. Burke
|
|
|
The imperative of mixed methods for cancer disparities research
|
Rena J. Pasick
|
|
|
Blending Methodologies to Optimize Cancer Disparities Research
|
Rena J. Pasick
|
|
|
Disparities in treatment decision making watchful waiting/expectant management of indolent prostate cancer
|
Mack Roach
|
July 15, 2010
|
Breast Cancer: Current Controversies | New Horizons
|
Are We Over-Diagnosing Pre-Invasive Disease?
|
Laura Esserman
|
May 19, 2010
|
Towards Personalized Cancer Medicine
|
The Cancer Genome and Therapeutics
|
J. Michael Bishop
|
April 30, 2010
|
UCSF Radiation Oncology Update: Management of Recurrent Disease
|
Surgical Salvage for Thoracic Recurrences
|
Michael Mann
|
|
|
Stereotactic Radiosurgery for Thoracic and Soft Tissue Malignancies
|
Alexander R. Gottschalk
|
|
|
GI/LUNG/SARCOMA TUMORS
|
Alexander R. Gottschalk
|
|
|
Opening Remarks
|
Mack Roach
|
|
|
Case Presentations and Panel Discussion
|
Igor J. Barani
|
|
|
Biology of Radiation Induced Tumors
|
Jean L. Nakamura
|
|
|
Surgical Management of Recurrent Spine Tumors
|
Dean Chou
|
|
|
CENTRAL NERVOUS SYSTEM TUMORS (CONT’D)
|
Jean L. Nakamura
|
|
|
Case Presentations and Panel Discussion
|
Penny K. Sneed
|
|
|
Molecular Predictors and Concurrent Biologic Therapies for Recurrent CNS Disease
|
Daphne Haas-Kogan
|
|
|
Clinical Trials for Recurrent GBM
|
Jennifer Clarke
|
|
|
Treatment of Recurrent Brain Metastases
|
Penny K. Sneed
|
|
|
Imaging Techniques for Differential Diagnosis of Recurrent Brain Lesions
|
Christopher P. Hess
|
|
|
Session Overview
|
Igor J. Barani
|
|
|
CENTRAL NERVOUS SYSTEM TUMORS
|
Igor J. Barani
|
|
|
Case Presentations and Panel Discussion
|
CHRIS J. DEIDERICH
|
|
|
UCSF Hyperthermia
|
CHRIS J. DEIDERICH
|
|
|
HYPERTHERMIA
|
CHRIS J. DEIDERICH
|
|
|
Case Presentations and Panel Discussion
|
Catherine C. Park
|
|
|
The Role of the Cancer Associated Stroma in Predicting Local Recurrence
|
Catherine C. Park
|
|
|
Chemotherapy for Isolated Recurrence: NSABP Trial
|
Hope S. Rugo
|
|
|
Surgical Issues in Management of Local Recurrence: Sentinel Nodes, Reconstruction
|
Eun-Sil (Shelley) Hwang
|
|
|
The Role of Radiation in the Treatment of Locally-regionally Recurrent Breast Cancer
|
Barbara L. Fowble
|
|
|
BREAST TUMORS
|
Catherine C. Park
|
|
|
Surgical Salvage for Ovarian Cancers
|
Lee-may Chen
|
|
|
Management of Recurrent Cervical Cancer
|
I-Chow Joe Hsu
|
|
|
GYNECOLOGIC TUMORS
|
I-Chow Joe Hsu
|
|
|
Case Presentations and Panel Discussion
|
Mack Roach
|
|
|
Systemic Management of Hormone Refractory Disease
|
Charles Ryan
|
|
|
Salvage Radiation for Local Recurrence: HDR and Brachytherapy
|
Mack Roach
|
|
|
Radiation after Post-operative Local Recurrence
|
Alexander R. Gottschalk
|
|
|
PROSTATE TUMORS
|
Alexander R. Gottschalk
|
January 29, 2010
|
9th Annual UCSF Clinical Cancer Update
|
Minimally Invasive Surgery for Resectable Lung Cancer: When Does Size Matter?
|
Jasleen Kukreja
|
|
|
Case Presentation/Panel Discussion:
|
Laurie Weisberg
|
|
|
Central Nervous System Lymphoma
|
James Rubenstein
|
|
|
Session 2: Hematology Oncology Session
|
Lloyd Damon
|
|
|
Session 1: Lung Cancer/Mesothelioma
|
Thierry M. Jahan
|
|
|
What’s New in Breast Cancer; Update from San Antonio 2009
|
Hope S. Rugo
|
|
|
Session 3: Breast Cancer Session
|
Hope S. Rugo
|
|
|
Lymphocyte Predominant Hodgkin’s Disease
|
Weiyn Ai
|
|
|
Personalized Medicine and Colorectal Cancer
|
Alan Venook
|
|
|
Selective Internal Radiation Therapy (SIRT) for GI Malignancies
|
Nicholas Fidelman
|
|
|
Updates in Renal Cell Cancer
|
Andrea Harzstark
|
|
|
Update in the Treatment of Prostate Cancer
|
Charles Ryan
|
|
|
Antiangiogenic Therapy for Malignant Glioma
|
Michael Prados
|
|
|
Session 6: Neurologic Cancer Session
|
Mitchel S. Berger
|
|
|
Case Presentation/Panel Discussion
|
Anne Espinoza
|
|
|
The Role of Surgery in the Treatment of GIST
|
Robert Warren
|
|
|
Current Clinical Trials
|
Nicholas Butowski
|
January 21, 2010
|
2010 DERMATOLOGY FOUNDATION CLINICAL SYMPOSIA: ADVANCES IN DERMATOLOGY
|
Vascular Birthmarks Update
|
Ilona J. Frieden
|
|
|
Nevoid & Segmental Pigment Disorders
|
Ilona J. Frieden
|
|
|
IV. Surgical Reconstruction: How We Do It
|
Isaac M. Neuhaus
|
|
|
Clinical Aspects of Psoriasis in Children
|
Kelly M. Cordoro
|
|
|
II. Managing Skin in Patients with Inflammatory Bowel Disease
|
Timothy G. Berger
|
|
|
Diagnostic Dilemmas from the West Coast
|
Timothy G. Berger
|
|
|
Update on Pre-Op Evaluation: Antibiotics and Anticoagulation Management
|
Isaac M. Neuhaus
|
|
|
I. Lumps & Bumps in Kids
|
Ilona J. Frieden
|
|
|
Hot Topic: Health Care Reform Update
|
Jack S. Resneck
|
|
|
I. Evidence-Based Work-Up of Chronic Urticaria in Children: How Much is Enough? How Much is Too Much?
|
Kelly M. Cordoro
|
|
|
The Itchy Elderly Patient – A New Approach
|
Timothy G. Berger
|
November 21, 2009
|
11th Annual UCSF/UC Davis Thoracic Oncology Conference
|
LOCALLY ADVANCED NSCLC
|
Lorriana Leard, Sue S. Yom
|
|
|
Novel Agents for Advanced NSCLC
|
Sarita Dubey
|
|
|
ADVANCED NON-SMALL CELL LUNG CANCER
|
Sarita Dubey
|
|
|
Welcome and Introduction
|
David M. Jablons
|
|
|
EARLY STAGE NSCLC
|
David M. Jablons, Jasleen Kukreja, Thierry M. Jahan, Sue S. Yom
|
|
|
Multi-Disciplinary Management of Esophageal Cancer
|
Pierre Theodore
|
|
|
Tumors Below the GE Junction - Operative Management and Strategies
|
Guilherme M. Campos
|
|
|
ESOPHAGEAL CANCER
|
Guilherme M. Campos, Pierre Theodore
|
|
|
TRANSLATIONAL UPDATE
|
David M. Jablons
|
|
|
World Perspective on the Treatment of Mesothelioma
|
Thierry M. Jahan
|
|
|
Case Presentation/Roundtable Discussion
|
Jasleen Kukreja
|
|
|
Neoadjuvant Chemotherapy: Has Its Time Come?
|
David M. Jablons
|
|
|
SMALL CELL LUNG CANCER
|
Sarita Dubey
|
November 12, 2009
|
Sixth International Conference - Revitalizing Cancer Care: Comprehensive Interdisciplinary Programs and Whole Systems Research
|
a. Integrative Oncology Residency/Fellowship Training
|
Donald Abrams
|
|
|
Research Overview
|
Anand Dhruva
|
|
|
2) Breakfast Satellite Session Targeting Angiogenesis: Pharmaceutical and Nutraceutical Approaches | a
|
Donald Abrams
|
|
|
Closing Session
|
Donald Abrams
|
October 26, 2009
|
Advanced Imaging Course Update
|
HCT of the Lung
|
Brett Elicker
|
|
|
Coronary CTA: Part II
|
Brett Elicker
|
|
|
Coronary CTA: Part I
|
Brett Elicker
|
October 16, 2009
|
Eighth Annual Controversies in Breast Cancer: Adjuvant and Neoadjuvant Therapy
|
The ISPY Trials: Initial Results and Directions for the Future
|
Laura Esserman
|
November 21, 2008
|
The 13th Annual Scientific Meeting of the Society for Neuro-Oncology
|
Response and Outcome Assessment in NeuroOncology: Update
|
Susan Chang
|
November 6, 2008
|
The 2008 Research Conference on Food, Nutrition, Physical Activity & Cancer
|
Split Session C: Molecular Signaling via Hedgehog and Wnt Pathways in Skin Cancer
|
Daniel D. Bikle
|
November 15, 2007
|
2007 Fourth International Conference
|
Effect of Stress on Telomeres and Telomerase
|
Elissa Epel
|